Radiation, and DNA-active chemicals, are generally cytotoxic, mutagenic, and oncogenic. Cell killing, which is essential in the therapy of cancer, is also important to the assessment of mutation and neoplastic transformation because cellular viability is required for both of these end effects to be expressed. Radiation is recognized as mutagenic and oncogenic in people and a number of the chemicals which are used in cancer therapy have similar properties. It follows, therefore, that the study of the biological effects of radiation and genotoxic chemicals is important both to issues of public health and to the treatment of cancer. This research will focus mainly on ionizing radiation although near-ultraviolet, sunlight-simulating light and certain chemicals will also be studied. A primary theme will be damage and repair processes in mammalian cells in culture as these processes influence lethality, mutagenesis, and neoplastic transformation. The underlying notion, which has applied to the work of the Principal Investigator over the past 30 years, is that the cell and molecular biology of damage and repair are opposite sides of the same coin. That is, progress on one aspect of the problem complements the understanding of the other. A study of mechanisms of damage and repair draws together the otherwise disparate features of the radiobiology of protracted low doses, as they may constitute an environmental hazard, and the radiobiology of single-to-protracted moderate-to-high radiation doses as they may be applied in tumor therapy. In addition, as therapy becomes more effective and lifespans are extended, the likelihood must be faced that second tumors may become expressed. An understanding of the mechanism of tumorigenesis could lead to the development of treatment strategies which minimize such risks. Thus, from another vantage point, this possibility also illustrates an essential coherence of the several parts of the proposed research.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Unknown (R35)
Project #
1R35CA047497-01
Application #
3479693
Study Section
(SRC)
Project Start
1988-05-01
Project End
1995-04-30
Budget Start
1988-05-01
Budget End
1989-04-30
Support Year
1
Fiscal Year
1988
Total Cost
Indirect Cost
Name
Colorado State University-Fort Collins
Department
Type
Schools of Veterinary Medicine
DUNS #
112617480
City
Fort Collins
State
CO
Country
United States
Zip Code
80523
Chernikova, S B; Lindquist, K L; Elkind, M M (2001) Cell cycle-dependent effects of wortmannin on radiation survival and mutation. Radiat Res 155:826-31
Lang, S; Marchesani, M; Servomaa, K et al. (1999) p53 gene mutations in neoplastic transformation of C3H 10T1/2 and severe combined immunodeficiency fibroblasts. Mutat Res 434:61-5
Chernikova, S B; Wells, R L; Elkind, M M (1999) Wortmannin sensitizes mammalian cells to radiation by inhibiting the DNA-dependent protein kinase-mediated rejoining of double-strand breaks. Radiat Res 151:159-66
Lun, M; Wells, R L; Lang, S et al. (1999) The neoplastic transformation of SCID cells by radiation. Radiat Res 152:180-9
Elkind, M M (1999) Does repair of radiation damage play a role in breast cancer? Radiat Res 152:567
Wells, R L; Hu, Q; Xing, Y et al. (1998) Phase transitions in the growth of C3H 10T1/2 cells. Radiat Res 149:508-16
Elkind, M M (1997) Cell-cycle sensitivity, recovery from radiation damage and a new paradigm for risk assessment. Int J Radiat Biol 71:657-65
Xing, Y; Wells, R L; Elkind, M M (1996) Nonradioisotopic PCR heteroduplex analysis: a rapid, reliable method of detecting minor gene mutations. Biotechniques 21:186-7
Elkind, M M (1996) Enhanced risks of cancer from protracted exposures to X- or gamma-rays: a radiobiological model of radiation-induced breast cancer. Br J Cancer 73:133-8
Shen, Z; Wells, R L; Elkind, M M (1994) Enhanced cytochrome P450 (Cyp1b1) expression, aryl hydrocarbon hydroxylase activity, cytotoxicity, and transformation of C3H 10T1/2 cells by dimethylbenz(a)anthracene in conditioned medium. Cancer Res 54:4052-6

Showing the most recent 10 out of 32 publications